K&L Gates’ Pharma & Biopharma Litigation group delivers its clients extensive experience, knowledge, and technical acumen to handle patent litigation around the world.

In the United States, Germany, Australia, and various arbitration fora, we counsel clients with a global perspective supported by a deep understanding of the science (organic chemistry, molecular biology, biochemistry, and pharmacology) as well as the venues (U.S. district courts, Patent Trial and Appeal Board, Federal Court of Australia, and the Unified Patent Court).

Our team is singularly focused on pharmaceutical patent work with a successful track record of representing pharmaceutical companies in more than 40 Hatch-Waxman cases over the past decade, numerous inter partes review (IPR) proceedings, hundreds of opinions, and thousands of patent applications.

Underpinning our work is a deep understanding of the pharmaceutical industry and technology from first-hand knowledge and experience:

  • 18 intellectual property lawyers with doctorates
  • 27 lawyers and agents with biotechnology-related degrees
  • 21 lawyers and agents with chemistry/chemical degrees
  • 34 with advanced degrees
  • 10 with in-house pharmaceutical experience